Geneseeq, Author at Geneseeq Technology Inc. | A Precision Oncology Company

June 13, 2022

Geneseeq Multicancer Early Detection Study Yields Promising Results

0 Comments3 Minutes

May 31, 2022

Geneseeq at ASCO 2022

0 Comments7 Minutes

May 19, 2022

Geneseeq collaborates on another minimal residual disease study in chemoradiotherapy-treated inoperable localized non-small cell lung cancer patients.

0 Comments3 Minutes

April 5, 2022

Geneseeq Presents 9 Posters at AACR 2022

0 Comments12 Minutes

January 4, 2022

Geneseeq’s cancer early detection study series DECIPHER yield another publication in HEPATOLOGY to explore the performance of cfDNA fragmentomics in liver cancer

0 Comments3 Minutes

November 22, 2021

Geneseeq announces new publication utilizing ultradeep sequencing technology Automated TTriple Groom sequencing (ATG-seq) to monitor minimal residual disease in postoperative non-small cell lung cancer

0 Comments3 Minutes

November 11, 2021

Geneseeq Forms Lung Cancer Strategic Partnerships with Takeda and AstraZeneca on the Same Day

0 Comments1 Minutes

November 8, 2021

Geneseeq collaborates on research identifying predictive biomarkers for guiding personalized adjuvant treatment in resected EGFR-positive non-small cell lung cancer

0 Comments4 Minutes

October 27, 2021

Geneseeq Study Shows High Performance Results in Colorectal Cancer Early Detection

0 Comments4 Minutes

October 13, 2021

Geneseeq and Zai Lab Announce Strategic Collaboration to Advance Cancer Drug R&D

0 Comments2 Minutes